Showing results (61-70 of 298) with videos related to
Sort By:
Pageof 30
American Heart Journal|August 28, 2007
Unrecognized glycometabolic disturbance as measured by hemoglobin A1c is associated with a poor outcome after acute myocardial infarctionIda Gustafsson, Caroline N Kistorp, Margaret K James, et al.The American Journal of Cardiology|October 21, 2009
The chemokine network in relation to infarct size and left ventricular remodeling following acute myocardial infarctionStein Orn, Unni M Breland, Tom Eirik Mollnes, et al.International Journal of Cardiology|August 16, 2008
B-type natriuretic peptide is related to histological skeletal muscle abnormalities in patients with chronic heart failureAlf Inge Larsen, Øyvind Skadberg, Torbjørn Aarsland, et al.Journal of Hypertension|April 24, 2018
Visit-to-visit blood pressure variation is associated with outcomes in a U-shaped fashion in patients with myocardial infarction complicated with systolic dysfunction and/or heart failure: findings from the EPHESUS and OPTIMAAL trialsJoão Pedro Ferreira, Kévin Duarte, Bertram Pitt, et al.European Journal of Heart Failure|October 26, 2012
Sildenafil in Heart failure (SilHF). An investigator-initiated multinational randomized controlled clinical trial: rationale and designTrond J Cooper, Marco Guazzi, Abdallah Al-Mohammad, et al.European Journal of Heart Failure|October 2, 2015
Effectiveness of an interactive platform, and the ESC/HFA heartfailurematters.org website in patients with heart failure: design of the multicentre randomized e-Vita heart failure trialKim P Wagenaar, Berna D L Broekhuizen, Kenneth Dickstein, et al.American Heart Journal|October 31, 2006
Prognostic value of plasma chromogranin A levels in patients with complicated myocardial infarctionMette Elise Estensen, Aina Hognestad, Unni Syversen, et al.European Heart Journal. Acute Cardiovascular Care|February 25, 2014
The Seattle Post Myocardial Infarction Model (SPIM): prediction of mortality after acute myocardial infarction with left ventricular dysfunctionEric S Ketchum, Kenneth Dickstein, John Kjekshus, et al.The American Journal of Cardiology|July 13, 2004
Effect of single doses of SLV306, an inhibitor of both neutral endopeptidase and endothelin-converting enzyme, on pulmonary pressures in congestive heart failureKenneth Dickstein, Hanka J De Voogd, Milutin P Miric, et al.European Heart Journal|August 8, 2006
Weight-change as a prognostic marker in 12 550 patients following acute myocardial infarction or with stable coronary artery diseaseLinn M A Kennedy, Kenneth Dickstein, Stefan D Anker, et al.Pageof 30